Importantly, CAD upregulation in PCa promotes androgen receptor (AR) nuclear translocation and transcriptional activity, therefore enhancing the metastatic capacity and recurrence risk of PCa [32]. The gene discussed is AR; the disease is posterior cortical atrophy.